- The Efficacy of Alpha-Interferon in Korean Patiens with Chronic Hepatitis B
-
Koh KC
- KMID: 760577
- Korean J Hepatol.
- 2005 Mar;11(1):31-33.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Efficacy of Peginterferon and Ribavirin Combination Therapy for Chronic Hepatitis C among Korean, Caucasian and Other Asians
-
Kim KA
- KMID: 1775791
- Korean J Gastroenterol.
- 2012 Nov;60(5):273-274.
- doi: 10.4166/kjg.2012.60.5.273
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?
-
Rou WS, Lee BS
- KMID: 2164361
- Clin Mol Hepatol.
- 2015 Jun;21(2):122-124.
- doi: 10.3350/cmh.2015.21.2.122
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Is peginterferon and ribavirin therapy effective in Korean patients with chronic hepatitis C?
-
Jung YK, Kim JH
- KMID: 1493571
- Clin Mol Hepatol.
- 2013 Mar;19(1):26-28.
- doi: 10.3350/cmh.2013.19.1.26
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy
-
Lee SJ, Cho YK, Na SY, Choi EK, Boo SJ, Jeong SU, Song HJ, Kim HU, Kim BS, Song BC
- KMID: 2373140
- Clin Mol Hepatol.
- 2016 Sep;22(3):390-395.
- doi: 10.3350/cmh.2015.0050
Some recent studies have found regression of liver cirrhosis after antiviral therapy in patients with hepatitis C virus (HCV)-related liver cirrhosis, but there have been no reports of complete regression... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients
-
Chung WJ
- KMID: 1392905
- Clin Mol Hepatol.
- 2012 Sep;18(3):268-271.
- doi: 10.3350/cmh.2012.18.3.268
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship Between Core Gene Mutations of Hepatitis B Virus and Response to Alpha Interferon Therapy in Chronic Hepatitis B
-
Yoo BC, Kim HJ, Do JH, Park SM
- KMID: 863113
- Korean J Hepatol.
- 2002 Dec;8(4):381-388.
BACKGROUND/AIMS: Treatment of chronic hepatitis B with interferon results in a sustained loss of hepatitis B virus DNA and hepatitis B e antigen (HBeAg) and remission of liver disease... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of a sustained virologic response in combination therapy with interferon/peginterferon and ribavirin for chronic hepatitis C
-
Kim CH, Park BD, Lee JW, Kim YS, Jeong S, Lee DH, Kim HG, Shin YW, Kwon KS, Lee JI
- KMID: 1776816
- Korean J Hepatol.
- 2009 Mar;15(1):70-79.
- doi: 10.3350/kjhep.2009.15.1.70
BACKGROUNDS/AIMS: The ultimate goal of antiviral therapy using interferon/pegylated interferon combined with ribavirin in chronic C-viral hepatitis is to achieve a sustained virologic response (SVR). Several studies have shown that... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of antiviral therapy for chronic hepatitis C after achieving sustained virological response
-
Heo J
- KMID: 1025196
- Korean J Hepatol.
- 2011 Sep;17(3):180-182.
- doi: 10.3350/kjhep.2011.17.3.180
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Pegylated Interferon Alpha-2a Monotherapy in a Peritoneal Dialysis Patient with Chronic Hepatitis C
-
Tae HJ, Jun DW, Choi JW, Kim WJ, Kim BY, Sohn JH, Lee MH
- KMID: 1718419
- Korean J Gastroenterol.
- 2011 Aug;58(2):107-110.
- doi: 10.4166/kjg.2011.58.2.107
Pegylated interferon (PEG-IFN) is now the standard treatment for chronic hepatitis C. But, there are few reports about patients with end stage renal disease, and treatment protocol for HCV infection... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of alanine aminotransferase dynamics on predicting sustained virological response in chronic hepatitis C virus infection
-
Kim TY
- KMID: 1372648
- Korean J Hepatol.
- 2012 Mar;18(1):29-31.
- doi: 10.3350/kjhep.2012.18.1.29
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- The First Reported Case of West Nile Encephalitis in Korea
-
Hwang J, Ryu HS, Kim H, Lee SA
- KMID: 2133315
- J Korean Med Sci.
- 2015 Mar;30(3):343-345.
- doi: 10.3346/jkms.2015.30.3.343
West Nile encephalitis was first identified in 1937, but until now, it was never diagnosed in Korea. A 58-yr-old Korean man was admitted with headache and cognitive dysfunction. The patient... -
- CITED
-
- Close
- SHARE
-
- Close
- Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B
-
Wi CI, Kim WR, Gross JB, Stadheim L, Poterucha
- KMID: 2412051
- Gut Liver.
- 2016 Jul;10(4):611-616.
- doi: 10.5009/gnl14256
BACKGROUND/AIMS: Despite the potent suppression of the hepatitis B virus with modern antiviral agents, only a minority of HBeAg-positive patients achieve hepatitis B e antigen seroconversion. We aimed to explore... -
- CITED
-
- Close
- SHARE
-
- Close
- Secreted Phosphoprotein 1 Promoter Genetic Variants Are Associated with the Response to Pegylated Interferon alpha Plus Ribavirin Combination Therapy in Egyptian Patients with Chronic Hepatitis C Virus Infection
-
Ali FT, Ali MA, Elgizawy M, Elsawy AM
- KMID: 2160636
- Gut Liver.
- 2015 Jul;9(4):516-524.
- doi: 10.5009/gnl14162
BACKGROUND/AIMS: The T-helper 1 (TH1) immune reaction is essential for the eradication of hepatitis C virus (HCV) during pegylated interferon alpha (PEG-IFN-alpha)- and ribavirin (RBV)-based therapy in chronic HCV patients.... -
- CITED
-
- Close
- SHARE
-
- Close
- Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study
-
Seo KI, Yun BC, Li WJ, Lee SU, Han BH, Park ET
- KMID: 2412117
- Clin Mol Hepatol.
- 2017 Mar;23(1):74-79.
- doi: 10.3350/cmh.2016.0052
BACKGROUND/AIMS: Interferon-based treatment is not appropriate for a large number of patients with chronic hepatitis C for various medical and social reasons. Newly developed directly acting antivirals (DAAs) have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Durability of a sustained virological response in chronic hepatitis C patients treated with pegylated interferon alfa and ribavirin
-
Choi SB, Lee YJ, Lee JI, Song YJ, Choi BJ, Kim JH, Jung EU, Park SJ, Lee SH, Kim JH, Choi JS, Jee SR, Seol SY
- KMID: 1025197
- Korean J Hepatol.
- 2011 Sep;17(3):183-188.
- doi: 10.3350/kjhep.2011.17.3.183
BACKGROUND/AIMS: The reappearance rates of hepatitis C virus (HCV) RNA after a sustained virological response (SVR) have been reported to be 1-2%. We investigated the reappearance rate of HCV RNA... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behcet's Disease
-
Park JY, Chung YR, Lee K, Song JH, Lee ES
- KMID: 2366362
- Yonsei Med J.
- 2015 Jul;56(4):1158-1162.
- doi: 10.3349/ymj.2015.56.4.1158
Behcet's disease (BD) involves multisystem vasculitis of unknown origin. Ocular manifestations of BD mostly include bilateral panuveitis and retinal vasculitis, which are very challenging to treat. Interferon alfa-2a (IFN) has... -
- CITED
-
- Close
- SHARE
-
- Close
- Peginterferon alpha and ribavirin combination therapy in patients with hepatitis C virus-related liver cirrhosis
-
Kim KH, Jang BK, Chung WJ, Hwang JS, Kweon YO, Tak WY, Lee HJ, Lee CH, Suh JI
- KMID: 1025202
- Korean J Hepatol.
- 2011 Sep;17(3):220-225.
- doi: 10.3350/kjhep.2011.17.3.220
BACKGROUND/AIMS: Pegylated interferon (peginterferon) and ribavirin combination therapy is less effective and associated with a higher frequency of serious complications in chronic hepatitis C patients with cirrhosis than in noncirrhotic... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of Peginterferon and Ribavirin Combination Therapy of Chronic Hepatitis C: A Pooled Analysis
-
Park SY, Rim MY, Yo IK, Ha MS, Kim JS, Lee JW, Jung YK, Kwon OS, Kim YS, Choi DJ, Kim JH
- KMID: 1775796
- Korean J Gastroenterol.
- 2012 Nov;60(5):306-314.
- doi: 10.4166/kjg.2012.60.5.306
BACKGROUND/AIMS: A combination of peginterferon and ribavirin is the standard therapy for chronic hepatitis C (CHC). However, the respective study has not been carried out in a large scale in... -
- CITED
-
- Close
- SHARE
-
- Close
- High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice
-
Heo NY, Lim YS, Lee HC, Lee YS, Kim KM, Byun KS, Han KH, Lee KS, Paik SW, Yoon SK, Suh DJ
- KMID: 1493576
- Clin Mol Hepatol.
- 2013 Mar;19(1):60-69.
- doi: 10.3350/cmh.2013.19.1.60
BACKGROUND/AIMS: Identifying the impact of a patient's ethnicity on treatment responses in clinical practice may assist in providing individualized treatment regimens for chronic hepatitis C (CHC). The effectiveness of standard... -
- CITED
-
- Close
- SHARE
-
- Close
